Kim Ji Eun, Kim Young A, Jeon Yoon Kyung, Park Sung Shin, Heo Dae Seog, Kim Chul Woo
Department of Pathology, Seoul Municipal Boramae Hospital, Korea.
Pathol Int. 2003 Nov;53(11):735-43. doi: 10.1046/j.1320-5463.2003.01552.x.
Natural killer/T-cell lymphoma (NKTL) and peripheral T-cell lymphomas (PTCL) are prevalent in the Asian population and exhibit a high association with the Epstein-Barr virus (EBV). Moreover, differentiation of these two groups is often difficult and problematic. We investigated 35 cases of NKTL (22 nasal cases and 13 extranasal cases) and 30 cases of PTCL in terms of their clinical features, immunohistology, EBV positivity, EBV strain-type polymorphism and latent membrane protein 1 (LMP1) deletion variant distribution. Eighteen cases (82%) of nasal NKTL and seven (54%) of extranasal NKTL showed EBV positivity by EBV in situ hybridization. Fifteen cases (50%) of PTCL revealed EBV positivity. EBV strain type A was predominant in NKTL (18:5), and EBV strain types A and B were distributed evenly in PTCL (6:6). EBV-positive patients had significantly shorter survival than EBV-negative patients (P < 0.05), and EBV positivity correlated with advanced clinical stage (P < 0.05). Patients harboring type A EBV showed slightly poorer prognoses than those having type B, though it was not obviously statistically different (P = 0.07). The LMP1 deletion variant was prevalent in both NKTL (three wild-type LMP1, 15 deletion variants) and PTCL (three wild-type LMP1, eight deletion variants, two coexistent forms) patients, but did not have prognostic impact. Our results indicate that EBV acts as a negative prognostic factor in NKTL and PTCL, and that the intrinsic properties of a specific viral strain might influence the clinical behavior of these diseases.
自然杀伤/T细胞淋巴瘤(NKTL)和外周T细胞淋巴瘤(PTCL)在亚洲人群中较为普遍,且与爱泼斯坦-巴尔病毒(EBV)高度相关。此外,这两组淋巴瘤的鉴别往往困难且存在问题。我们从临床特征、免疫组织学、EBV阳性率、EBV毒株类型多态性以及潜伏膜蛋白1(LMP1)缺失变异体分布方面,对35例NKTL(22例鼻腔病例和13例鼻腔外病例)和30例PTCL进行了研究。18例(82%)鼻腔NKTL和7例(54%)鼻腔外NKTL通过EBV原位杂交显示EBV阳性。15例(50%)PTCL显示EBV阳性。EBV毒株A型在NKTL中占主导(18:5),而EBV毒株A和B在PTCL中分布均匀(6:6)。EBV阳性患者的生存期明显短于EBV阴性患者(P < 0.05),且EBV阳性与临床晚期相关(P < 0.05)。携带A型EBV的患者预后略逊于携带B型的患者,尽管差异无统计学意义(P = 0.07)。LMP1缺失变异体在NKTL(3例野生型LMP1,15例缺失变异体)和PTCL(3例野生型LMP1,8例缺失变异体,2种共存形式)患者中均较为普遍,但对预后无影响。我们的结果表明,EBV在NKTL和PTCL中是一个负面预后因素,特定病毒毒株的内在特性可能会影响这些疾病的临床行为。